BELLESE TECHNOLOGIES, LLC: $25.8M Department of Health and Human Services Contract
Summary
This $25.8M contract to private firm Bellese Technologies for CMS hospital quality reporting is a sector signal for healthcare IT spending, but no publicly traded company is directly tied. The award aligns with healthcare transparency bills like HR8324, but lacks a public beneficiary.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.Bellese Technologies is private; no public ticker exposure.
- 2.Contract is a routine bridge renewal for hospital quality reporting.
- 3.Healthcare IT sector remains stable but no catalyst from this award.
Market Implications
This contract does not directly affect any publicly traded company, so market implications are minimal. The healthcare IT sector may see indirect benefits from sustained government spending on quality reporting, but without a public recipient, no stock movement is expected. Investors should monitor future awards to public firms like Cerner (now Oracle Health) or Epic Systems (private) for clearer signals.
Full Analysis
The Centers for Medicare and Medicaid Services awarded Bellese Technologies, LLC a $25.8M delivery order for the Hospital Quality Reporting (HQR) II Bridge contract, covering a one-year period from May 2026 to May 2027. Bellese Technologies is a private entity with no publicly traded parent or recognized subsidiary, so no direct stock impact can be attributed. The contract supports CMS's ongoing efforts to collect and report hospital quality data, a function critical to value-based care initiatives. In the healthcare IT sector, this award signals continued federal investment in quality measurement infrastructure, which benefits private firms like Bellese and potentially subcontractors, but no public tickers are identifiable from available data. Related legislation such as HR8324 (Great American Healthcare Plan) and HR8857 (adjusting drug price negotiation) indicate a bullish legislative environment for healthcare transparency, but this specific contract is a routine bridge renewal rather than a transformative award. Without a public company recipient, supply chain beneficiaries cannot be reliably identified, and historical patterns for private-entity contracts show no direct market movement. The neutral sentiment reflects the lack of a public equity link, though the contract reinforces steady demand for healthcare data services.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Great American Healthcare Plan
To amend title XI of the Social Security Act to adjust which engineered cyclic peptides are qualifying single source drugs for purposes of the Drug Price Negotiation Program.
DELL FEDERAL SYSTEMS L.P: $1.0B Department of Veterans Affairs Contract
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $641M Department of Veterans Affairs Contract
FERMI FORWARD DISCOVERY GROUP, LLC: $2.4B Department of Energy Contract
FERMI FORWARD DISCOVERY GROUP, LLC: $2.4B Department of Energy Contract
FERMI FORWARD DISCOVERY GROUP, LLC: $2.4B Department of Energy Contract
HII MISSION TECHNOLOGIES CORP: $579M General Services Administration Contract
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Establishing an America First Arms Transfer Strategy
This executive order directs the Secretary of War, along with the Secretaries of State and Commerce, to create an 'America First Arms Transfer Strategy' that prioritizes foreign arms sales to boost U.S. defense industrial base capacity, streamline export processes, and enhance production of key weapons systems. It mandates a sales catalog of prioritized platforms within 120 days, forms a task force to improve coordination, and reforms congressional notification procedures for arms transfers.
Ushering in the Next Frontier of Quantum Innovation
This executive order updates the National Quantum Strategy and establishes a national effort (QC-ADDS) to develop a quantum computer for scientific discovery, with deployment at a Department of Energy facility. It directs multiple agencies to prioritize quantum sensing, networking, and supply chain initiatives, and mandates plans for commercial readiness and national security applications.
Contract Details
Recipient
BELLESE TECHNOLOGIES, LLC
Award Amount
$25,772,226
Awarding Agency
Department of Health and Human Services
Sub-Agency
Centers for Medicare and Medicaid Services
Contract Type
DELIVERY ORDER
Related Bills
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →